H.R. 10649, Opioid Disposal Infrastructure Funding via Manufacturer Fee. Quorum's AI analysis reads it as a trade-off: gains for some, costs for others.
H.R. 10649 · Mixed
What it does
This bill amends the Comprehensive Addiction and Recovery Act to authorize the Attorney General to award grants to establish or maintain prescription medication disposal sites, funded by a new 1-cent-per-100-milligrams fee on opioid sales. Cancer patients, hospice patients, and their families are exempted from paying the fee through a discount mechanism administered by HHS.
The analysis names Entities awarded disposal-site grants (law enforcement, nonprofits, healthcare systems) — and 1 more group — among the beneficiaries.
The trade-off
The 1-cent fee is per 100mg of active opioid, meaning higher-dose formulations incur proportionally higher fees; manufacturers may pass costs to consumers, potentially increasing out-of-pocket costs for non-exempted patients.
Transparency scores 85%, with a medium warning level and no provisions unrelated to the bill's subject.
Who is behind it
Filed by Suzanne Bonamici. Cosponsored by Riley Moore.
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.